Content
Frontiers of Medicine >> 2020, Volume 14, Issue 6 doi: 10.1007/s11684-020-0759-8
Precision medicine in acute lymphoblastic leukemia
Departments of Oncology and Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
Abstract
Keywords
acute lymphoblastic leukemia ; molecular therapeutics ; targeted therapy ; tyrosine kinase inhibitors ; immunotherapy ; CAR T-cell therapy
Content